Financials in USD. Standardized financial statements.
A compact view of how MabCure, Inc. turns revenue into operating income and net income.
| Metric | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 |
|---|---|---|---|---|---|---|
| Revenue? | $500,000 | $0 | $0 | $0 | $0 | $0 |
| Revenue Growth? | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit? | $500,000 | $0 | $0 | $0 | $0 | $0 |
| Gross Margin? | +100.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | $1.21M | $1.02M | $1.36M | $535,964 | $106,265 | $4,000 |
| Operating Income? | -$709,745 | -$1.02M | -$1.36M | -$535,964 | -$106,265 | -$4,000 |
| EBITDA? | -$12.05M | -$975,869 | -$1.31M | -$526,018 | -$106,265 | -$4,000 |
| Income Before Tax | -$12.26M | -$1.23M | -$1.37M | -$530,508 | $0 | $0 |
| Income Tax Expense | $186,661 | $206,852 | $16,699 | $970 | $106,265 | $4,000 |
| Net Income? | -$12.45M | -$1.43M | -$1.39M | -$531,478 | -$106,265 | -$4,000 |
| EPS? | $-0.20 | $-0.02 | $-0.02 | $-0.01 | $-0.00 | $-0.00 |
| Diluted EPS? | $-0.20 | $-0.02 | $-0.02 | $-0.01 | $-0.00 | $-0.00 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality